The suprachiasmatic nucleus (SCN) was first identified as the central circadian clock 50 years ago and has been the focus of extensive research. This review summarizes the key developments in the field over the past 25 years, highlighting new mechanisms and concepts that have emerged. Since 1997, advances in methods such as luminescence and fluorescence reporter techniques have revealed intricate relationships between cellular and network-level mechanisms. Specific neuropeptides, such as arginine vasopressin (AVP), vasoactive intestinal peptide (VIP), and gastrin releasing peptide (GRP), have been identified as key players in the synchronization of cellular circadian rhythms within the SCN. The discovery of multiple oscillators governing behavioral and physiological rhythms has significantly advanced our understanding of the circadian clock. The interaction between neurons and glial cells has been found to play a crucial role in regulating these circadian rhythms within the SCN. Furthermore, the properties of the SCN network vary across ontogenetic stages. The application of cell type-specific genetic manipulations has revealed components of the functional input-output system of the SCN and their correlation with physiological functions. This review concludes with the high-risk effort of identifying open questions and challenges that lie ahead. The SCN has been shown to function as a circadian pacemaker, with evidence from transplantation studies demonstrating its ability to restore rhythmicity in arrhythmic rodents. The discovery of mammalian clock genes in the 1990s revolutionized the field, revealing that intrinsic rhythmicity is not limited to the SCN but is widespread in other brain areas and peripheral tissues. Advances in genomics, gene editing, and imaging techniques have enabled detailed studies of the SCN's structure and function, including the identification of distinct core and shell subregions. These studies have revealed the complexity of SCN circuits and the importance of cell-to-cell communication in maintaining coherent circadian rhythms. The SCN also plays a critical role in regulating various physiological and behavioral outputs, including sleep, body temperature, and melatonin production. The field has made significant progress in understanding the molecular mechanisms of circadian rhythms, with the identification of key clock genes such as CLOCK, BMAL1, and PER. The SCN's ability to generate and maintain circadian rhythms is supported by a network of neurons and glial cells, with the discovery of diffusible signals and the role of neuropeptides in synchronizing oscillations. The SCN's outputs to various brain regions and peripheral tissues highlight its central role in coordinating circadian rhythms across the body. The field continues to explore the molecular and cellular mechanisms underlying circadian rhythms, with ongoing research into the role of the SCN in health and disease.The suprachiasmatic nucleus (SCN) was first identified as the central circadian clock 50 years ago and has been the focus of extensive research. This review summarizes the key developments in the field over the past 25 years, highlighting new mechanisms and concepts that have emerged. Since 1997, advances in methods such as luminescence and fluorescence reporter techniques have revealed intricate relationships between cellular and network-level mechanisms. Specific neuropeptides, such as arginine vasopressin (AVP), vasoactive intestinal peptide (VIP), and gastrin releasing peptide (GRP), have been identified as key players in the synchronization of cellular circadian rhythms within the SCN. The discovery of multiple oscillators governing behavioral and physiological rhythms has significantly advanced our understanding of the circadian clock. The interaction between neurons and glial cells has been found to play a crucial role in regulating these circadian rhythms within the SCN. Furthermore, the properties of the SCN network vary across ontogenetic stages. The application of cell type-specific genetic manipulations has revealed components of the functional input-output system of the SCN and their correlation with physiological functions. This review concludes with the high-risk effort of identifying open questions and challenges that lie ahead. The SCN has been shown to function as a circadian pacemaker, with evidence from transplantation studies demonstrating its ability to restore rhythmicity in arrhythmic rodents. The discovery of mammalian clock genes in the 1990s revolutionized the field, revealing that intrinsic rhythmicity is not limited to the SCN but is widespread in other brain areas and peripheral tissues. Advances in genomics, gene editing, and imaging techniques have enabled detailed studies of the SCN's structure and function, including the identification of distinct core and shell subregions. These studies have revealed the complexity of SCN circuits and the importance of cell-to-cell communication in maintaining coherent circadian rhythms. The SCN also plays a critical role in regulating various physiological and behavioral outputs, including sleep, body temperature, and melatonin production. The field has made significant progress in understanding the molecular mechanisms of circadian rhythms, with the identification of key clock genes such as CLOCK, BMAL1, and PER. The SCN's ability to generate and maintain circadian rhythms is supported by a network of neurons and glial cells, with the discovery of diffusible signals and the role of neuropeptides in synchronizing oscillations. The SCN's outputs to various brain regions and peripheral tissues highlight its central role in coordinating circadian rhythms across the body. The field continues to explore the molecular and cellular mechanisms underlying circadian rhythms, with ongoing research into the role of the SCN in health and disease.